ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Type 1 Diabetes Mellitus
Obesity
Diabetic Foot
Foot Ulcer
Overweight

Diabetes trials near Charlotte, NC, USA:

Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers

The study will evaluate the safety and performance of Symphony™ versus Standard of Care (SOC) in the treatment of chronic non-healing diabetic...

Enrolling
Diabetic Foot
Diabetic Foot Ulcer
Device: Symphony™ plus Off-loading
Device: Wound Dressing comprising of calcium alginate Fibracol
Aroa Biosurgery

Gastonia, North Carolina, United States and 10 other locations

Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.

The goal of this clinical trial is to learn if using perinatal tissue allografts improves healing of chronic, non-healing foot ulcers in diabetic...

Enrolling
Diabetic Foot Ulcer
Other: Three-layer fenestrated perinatal tissue allograft
Other: Dual-layer perinatal tissue allograft
Samaritan Biologics

Monroe, North Carolina, United States of America

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Charlotte, North Carolina, United States of America and 182 other locations

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Enrolling
Diabetes Mellitus, Type 2
Diabetic Peripheral Neuropathy
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk
Novo Nordisk

Statesville, North Carolina, United States and 54 other locations

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

Statesville, North Carolina, United States and 96 other locations

A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm (PAVILION)

Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Ma...

Active, not recruiting
Diabetic Retinopathy
Drug: PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
Drug: Intravitreal Ranibizumab 0.5 mg Injection

Phase 3

Roche
Roche

Charlotte, North Carolina, United States and 75 other locations

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes

control in participants with obesity or with overweight and type 2 diabetes. This trial is part of the master protocol study J2A-MC-GZPO.Par...

Enrolling
Type 2 Diabetes
Overweight
Drug: Orforglipron
Drug: Placebo

Phase 3

Lilly
Lilly

Charlotte, North Carolina, United States and 88 other locations

A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes

participants who have obesity or overweight with or without type 2 diabetes. Participants will be screened for about 4 weeks, after which th...

Enrolling
Type 2 Diabetes
Overweight
Drug: Placebo
Drug: Orforglipron

Phase 3

Lilly
Lilly

Charlotte, North Carolina, United States and 88 other locations

A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)

This study is comparing the medicine RYBELSUS® to other medicines in people with type 2 diabetes who need extra treatment. All medicines use...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: semaglutide
Drug: oral glucose-lowering medications (commercially available)

Phase 4

Novo Nordisk
Novo Nordisk

Charlotte, North Carolina, United States and 22 other locations

A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes

Phase II study aims to evaluate the efficacy, tolerability, and safety of RO7795081 for glycemic control in adult participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus
Drug: Semaglutide
Drug: Placebo

Phase 2

Roche
Roche

Statesville, North Carolina, United States and 17 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2025 Veeva Systems